Sign In
Buy CASI
$0.208
+0 (+0%)
At Close: May 22, 2026
CASI PHARMACEUTICALS ANNOUNCES MARKET APPROVAL OF CNCT19 BY CHINA NMPA
07:00am, Wednesday, 08'th Nov 2023
BEIJING , Nov. 8, 2023 /PRNewswire/ -- CASI Pharmaceuticals Inc. (Nasdaq: CASI), a biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical produc
CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2023 BUSINESS AND FINANCIAL UPDATES
07:00am, Friday, 11'th Aug 2023
BEIJING , Aug. 11, 2023 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical prod
BEIJING , Aug. 1, 2023 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical produ
CASI Pharmaceuticals Acquires Global Intellectual Property Rights to Cleave Therapeutics' VCP/P97 Inhibitor CB-5339
08:00am, Thursday, 20'th Jul 2023
BEIJING , July 20, 2023 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical prod
Casi Pharmaceuticals to run clinical trial for multiple myeloma drug in China
08:42am, Friday, 06'th Jan 2023
Shares of Casi Pharmaceuticals Inc. CASI, +3.63% were up 10% in premarket trading on Friday after the company said China will allow a Phase 1 clinical trial evaluating a multiple myeloma drug develope
CASI Pharmaceuticals, Inc. (CASI) Reports Q3 Loss, Lags Revenue Estimates
01:15pm, Monday, 14'th Nov 2022 Zacks Investment Research
CASI Pharmaceuticals, Inc. (CASI) delivered earnings and revenue surprises of 25.49% and 1.80%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the
CASI Pharmaceuticals, Inc. (CASI) Reports Q3 Loss, Lags Revenue Estimates
09:47am, Monday, 14'th Nov 2022
CASI Pharmaceuticals, Inc. (CASI) delivered earnings and revenue surprises of 25.49% and 1.80%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the
Gain Therapeutics, Inc. (GANX) Reports Q3 Loss, Lags Revenue Estimates
10:15pm, Thursday, 10'th Nov 2022 Zacks Investment Research
Gain Therapeutics, Inc. (GANX) delivered earnings and revenue surprises of 17.39% and 100%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the sto
Scynexis (SCYX) Reports Q3 Loss, Misses Revenue Estimates
01:15pm, Wednesday, 09'th Nov 2022 Zacks Investment Research
Scynexis (SCYX) delivered earnings and revenue surprises of -21.57% and 17.49%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
07:43am, Monday, 26'th Sep 2022 Benzinga
Gainers
Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday.
Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares climbed 46.4% to close at $0.3750 on Friday.
$2.2 Million Bet On Terns Pharmaceuticals? Check Out These 4 Penny Stocks Insiders Are Buying
02:32pm, Friday, 09'th Sep 2022 Benzinga
The Dow Jones closed higher by around 193 points on Thursday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or conc
The Dow Jones closed higher by around 193 points on Thursday. Investors, meanwhile, focused on some notable insider trades.
CASI Pharmaceuticals And 2 Other Stocks Under $4 Insiders Are Aggressively Buying
12:58pm, Monday, 29'th Aug 2022 Benzinga
The Dow Jones tumbled by over 1,000 points on Friday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern arou
CASI Pharmaceuticals And 2 Other Stocks Under $4 Insiders Are Aggressively Buying
08:58am, Monday, 29'th Aug 2022
The Dow Jones tumbled by over 1,000 points on Friday. Investors, meanwhile, focused on some notable insider trades.
This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday
09:38am, Wednesday, 17'th Aug 2022 Benzinga
Gainers
Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids.
Vinco Ventures, Inc. (NASDAQ: BBIG) gained 58.8% to settle a
